JYSZ2400041 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | License Renew | 2024-07-06 | | | | | view |
JYSZ2400040 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | License Renew | 2024-07-06 | | | | | view |
JYSB2400111 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-05-17 | | Sanofi Winthrop Industrie | | | view |
JYSB2400110 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-05-17 | | Sanofi Winthrop Industrie | | | view |
JYSB2400109 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-05-17 | | Sanofi Winthrop Industrie | | | view |
JYSB2400108 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-05-17 | | Sanofi Winthrop Industrie | | | view |
JYSB2400077 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-04-04 | | | | | view |
JYSB2400076 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-04-04 | | | | | view |
JYSB2300135 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2023-08-15 | | | | | view |
JYSB2300134 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2023-08-15 | | | | | view |
JYSB2200208 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2022-10-22 | | | | | view |
JYSB2200207 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2022-10-22 | | | | | view |
JYSB2200175 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2022-09-09 | | | | | view |
JYSB2200174 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2022-09-09 | | | | | view |
JYSB2200081 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2022-05-07 | | | | | view |
JYSB2200080 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2022-05-07 | | | | | view |
JYSB2000683 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Supplementary Application | 2021-01-01 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-09-22 | view |
JYSB2000388 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Supplementary Application | 2020-08-21 | Sanofi-aventis groupe | Sanofi-Aventis Groupe | Filed | 2020-09-02 | view |
JXSS2400003 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-01-25 | | | | | view |
JXSS2400002 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-01-25 | | | | | view |